Latest News in the pharma Industry

Top Stories

Addex Regains Parkinson's Programme Rights from Merck

Addex Regains Parkinson's Programme Rights from Merck

7 Sep 2011

Merck originally licensed the rights to the programme in 2007 in a deal potentially worth as much as $170.5m.

Read more 
Pfizer & Sanofi Sign Deal for Generic Lipitor

Pfizer & Sanofi Sign Deal for Generic Lipitor

6 Sep 2011

Pfizer has granted Sanofi a licence to manufacture a generic version of the product and launch it after Lipitor's patent expires in the country on 7 May 2012.

Read more 
Oxford Pharmascience Licenses Colonic Drug Delivery Technology

Oxford Pharmascience Licenses Colonic Drug Delivery Technology

6 Sep 2011

Oxford Pharmascience partners with University of London to have the option to license and research an advanced colonic drug delivery technology.

Read more 
AstraZeneca's Crestor Fails to Best Lipitor in Study

AstraZeneca's Crestor Fails to Best Lipitor in Study

6 Sep 2011

According to trial results announced recently, Crestor, the statin drug from AstraZeneca, failed to best Lipitor at clearing clogged arteries.

Read more 
Pfizer Inks Lease Deal with MIT for New Research Center

Pfizer Inks Lease Deal with MIT for New Research Center

5 Sep 2011

The new research site will be Pfizer’s Cardiovascular, Metabolic and Endocrine Disease (CVMED) and Neuroscience Research Units.

Read more 
Pfizer & Dr Reddy's Settle Lipitor Patent Lawsuit

Pfizer & Dr Reddy's Settle Lipitor Patent Lawsuit

5 Sep 2011

Pfizer, the world’s largest drugmaker, settles a lawsuit with the Indian generic-drug maker Dr. Reddy’s Laboratories over the cholesterol treatment Lipitor.

Read more 
Teva Inks Cancer Pact with UK's Sinclair IS

Teva Inks Cancer Pact with UK's Sinclair IS

5 Sep 2011

Teva has signed an agreement with Sinclair IS to gain exclusive commercialisation rights of oncology medication Episil in Germany, Spain, Poland, Switzerland and the Czech Republic.

Read more 
Bayer Healthcare to Acquire Pathway Medical Technologies

Bayer Healthcare to Acquire Pathway Medical Technologies

2 Sep 2011

Bayer HealthCare's affiliate, MEDRAD, Inc. acquires Pathway Medical Technologies to strengthen its MEDRAD Interventional business by expanding its presence in the field of vascular intervention technologies.

Read more 
OXiGENE to Restructure to Focus  Clinical Resources on Earlier Stage Development Programs

OXiGENE to Restructure to Focus Clinical Resources on Earlier Stage Development Programs

2 Sep 2011

Biopharmaceutical firm OXiGENE, Inc. decides to restructure in an to focus resources on its most promising early-stage clinical programs.

Read more 
Pfizer Extends Tender Offer to Acquire Icagen

Pfizer Extends Tender Offer to Acquire Icagen

2 Sep 2011

Pfizer's subsidiary, Eclipse Acquisition Corp. , has extended the expiration date of its tender offer for Icagen.

Read more 
BMS Chooses ICON as Provider for Clinical Services

BMS Chooses ICON as Provider for Clinical Services

31 Aug 2011

Under the agreement, ICON will become a preferred provider for full-service clinical pharmacology and exploratory clinical studies.

Read more 
Valeant to Acquire Afexa for $76M

Valeant to Acquire Afexa for $76M

31 Aug 2011

Valeant Pharmaceuticals will acquire cold and flu medicine maker Afexa Life Sciences for approximately $76 million.

Read more